ARCHIVES

NCI Offers Coded Serum Panels

This article is from The Cancer Letter archive.

Vol. 08 No. 22 | May 28, 1982

Download PDF Visit The Full Archive

Related Articles

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

March 2, 2001

In Brief: Senate Health Subcommittee Lineup Completed; GAO Calls For More Ionizing Radiation Studies

January 23, 1981

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

Panel Suggests Test Of Paid Advertising For ACS: Roundup

August 7, 1992

NIH Clinical Trials Committee Adopts Recommendations For Safety Monitoring

June 22, 1979